Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2016-11-30
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to compare absorbable and non-absorbable sutures in patients undergoing peripheral vascular surgery with vein bypass grafting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wound Vac Polypropylene Suture Pilot Study
NCT02929238
Comparison of Cosmetic Outcomes of Lacerations Repaired Using Absorbable Versus Non-absorbable Sutures
NCT00933829
Mass Continous Suture With PDS Versus Interrupted Suture With Thread on Major Abdominal Incision
NCT03801421
Effect of Replacing Buried Sutures With Tissue Adhesive on Aesthetic Outcome of Surgical Wounds.
NCT03425370
Abdominal Wall Closure With Triclosan-coated Suture
NCT01620294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is an open-label, parallel group study.
Patients undergoing vein bass grafting for CLI or PAA may be suitable for entry into ASPeVas trial. They must satisfy the following inclusion criteria:
Both sex. Age \> 18 years old. Patients undergoing femoropopliteal or femorodistal vein bypass grafting; must be able to give informed consent; have no significant co-morbidity that makes life expectancy less than six months.
The randomisation process consists as follows: once a patient have consented entering the trial, an envelop is opened and the patient is offered the type of suture (absorbable or non absorbable) regardless of the surgical technique which is going to be performed (femoropopliteal or femorodistal vein bypass grafting).
All patients have to be followed-up, the day after the operation (time 0) and then subsequently at 1, 3,6,9,12 and 18 months.
At each appointment, Ankle Brachial Pressure Index (ABPI) is measured and then Duplex scanning (DS) is performed. In particular, by means of DS the peak systolic flow velocity (PSFV) at multiple sites along the entire graft is measured. A graft at risk of failure was defined as having a PSFV \< 45 cm/s or a ratio of V2 (peak velocity at the site of the stenosis) to V1 (peak systolic velocity at any other point within 2 cm at the normal adjacent graft) \> 2. Any other irregularities, such as inflow/outflow problems, graft dilatation will be also recorded.
Clinical signs of a failing graft will be collected: disabling claudication, ischemic pain, ischemic ulcers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Absorbable Group
In this group of patients absorbable sutures will be used for vascular anastomoses.
Absorbable suture
Vascular anastomoses will be performed with absorbable materials
Non-Absorbable Group
In this group of patients non-absorbable sutures will be used for vascular anastomoses.
Non-Absorbable suture
Vascular anastomoses will be performed with non-absorbable materials
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Absorbable suture
Vascular anastomoses will be performed with absorbable materials
Non-Absorbable suture
Vascular anastomoses will be performed with non-absorbable materials
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients able to give informed consent;
* Patients having no significant co-morbidity that makes life expectancy less than six months.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Catanzaro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Raffaele Serra, MD, Ph.D.
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raffaele Serra, M.D., PhD.
Role: PRINCIPAL_INVESTIGATOR
University Magna Graecia of Catanzaro
Stefano de Franciscis, M.D.
Role: STUDY_CHAIR
University Magna Graecia of Catanzaro
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Gasbarro V, Traina L, Mascoli F, Coscia V, Buffone G, Grande R, Fugetto F, Butrico L, de Franciscis S, Serra R. Absorbable suture material in carotid surgery. Vasa. 2015 Nov;44(6):451-7. doi: 10.1024/0301-1526/a000468.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ER.ALL.2016.02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.